Literature DB >> 118020

Sulphr containing amino acids in chronic renal failure with particular reference to homocystine and cysteine-homocysteine mixed disulphide.

D E Wilcken, V J Gupta.   

Abstract

We measured plasma sulphur amino acids in twenty-two patients with chronic renal failure and compared the findings with those obtained in twenty-two normal subjects. In fasting blood (08.00 hours) cysteine-homocysteine mixed disulphide was significantly increased in the renal patients, mean values (+/- SD) being 8.2 +/- 3.4 and 3.1 +/- 1.0 mumol/l respectively (P less than 0.001). The increase was positively correlated with reduced renal function, as assessed by serum creatinine (r = 0.62; P less than 0.01). Homocystine was detected in nineteen patients, the mean concentration (+/- SD) being 1.7 +/- 0.6 mumol/l; it was not found in any normal subject. Methionine levels were not different but there were significant increases in cystine (P less than 0.001) and taurine (P less than 0.05) in the patients. Similar values for these amino acids were found in a second blood sample drawn at 16.00 hours. Changes in the other neutral and acidic amino acids measured were in agreement with those reported in chronic azotaemia. We concluded that plasma levels of all the principal sulphur amino acids except methionine are elevated in chronic renal failure emphasizing the importance of the kidney in sulphur excretion. Prolonged accumulation of homocysteine and cysteine-homocysteine mixed disulphide may be relevant to the development of accelerated vascular disease in patients with chronic renal failure by producing endothelial damage.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 118020     DOI: 10.1111/j.1365-2362.1979.tb00888.x

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  11 in total

1.  In vitro susceptibilities of clinical isolates of cysteine-requiring Escherichia coli to 12 antimicrobial agents.

Authors:  C J McIver; J W Tapsall
Journal:  Antimicrob Agents Chemother       Date:  1991-05       Impact factor: 5.191

2.  S phase entry causes homocysteine-induced death while ataxia telangiectasia and Rad3 related protein functions anti-apoptotically to protect neurons.

Authors:  Weizhen Ye; Stacy W Blain
Journal:  Brain       Date:  2010-07-17       Impact factor: 13.501

3.  Unique efficiency of methionine metabolism in premenopausal women may protect against vascular disease in the reproductive years.

Authors:  G H Boers; A G Smals; F J Trijbels; A I Leermakers; P W Kloppenborg
Journal:  J Clin Invest       Date:  1983-12       Impact factor: 14.808

Review 4.  [Atherosclerosis and uremia: signifance of non-traditional risk factors].

Authors:  Walter H Hörl
Journal:  Wien Klin Wochenschr       Date:  2003-04-30       Impact factor: 1.704

5.  Homocysteine and C-reactive protein levels in haemodialysis patients.

Authors:  E Koulouridis; M Tzilianos; A Katsarou; I Costimba; E Klonou; E Panagiotaki; C Georgalidis; A Krokida; N Delaportas; A Lachanas; G Karaliotas; I Kaliolia
Journal:  Int Urol Nephrol       Date:  2001       Impact factor: 2.370

6.  Endothelial cell injury due to copper-catalyzed hydrogen peroxide generation from homocysteine.

Authors:  G Starkebaum; J M Harlan
Journal:  J Clin Invest       Date:  1986-04       Impact factor: 14.808

7.  Recurrent unprovoked venous thromboembolism in a young female patient with high levels of homocysteine.

Authors:  Ashish Anil Sule; Tay Jam Chin; Lee Hwei Khien
Journal:  Int J Angiol       Date:  2012-06

Review 8.  Translational Aspects of Sphingolipid Metabolism in Renal Disorders.

Authors:  Alaa Abou Daher; Tatiana El Jalkh; Assaad A Eid; Alessia Fornoni; Brian Marples; Youssef H Zeidan
Journal:  Int J Mol Sci       Date:  2017-11-25       Impact factor: 5.923

9.  Clinical Implications of Methylenetetrahydrofolate Reductase Mutations and Plasma Homocysteine Levels in Patients with Thromboembolic Occlusion.

Authors:  Won-Cheol Park; Jeong-Hwan Chang
Journal:  Vasc Specialist Int       Date:  2014-12-31

10.  Thiol/Disulfide Balance in Patients with Familial Hypercholesterolemia.

Authors:  Özgür Şimşek; Ayşe Çarlıoğlu; Murat Alışık; Efe Edem; Cemile Koca Biçer
Journal:  Cardiol Res Pract       Date:  2018-06-12       Impact factor: 1.866

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.